Skip to main content


Figure 1 | Cancer Cell International

Figure 1

From: The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy

Figure 1

The plasma of NSCLC patients was endowed with stimulatory activity. (A) PBMCs derived from normal volunteers were cultured in the presence of 20% plasma derived from normal donors or from NSCLC patients before treatment, or control plasma (20% fetal bovine serum). Data points represented individual patients. *P < 0.001 (B) PBMCs derived from 16 normal volunteers or from 28 NSCLC patients were tested for the expression of the indicated cytokines using quantitative PCR. *P < 0.001. Each bar represented the means (±SD) from 16 normal volunteers or from 28 NSCLC patients.

Back to article page